Back to 
JACOBS LEVY EQUITY MANAGEMENT, INC
JACOBS LEVY EQUITY MANAGEMENT, INC
RAREShowing 7 of 21 quarters
Position history for JACOBS LEVY EQUITY MANAGEMENT, INC's holdings in ULTRAGENYX PHARMACEUTICAL IN
JACOBS LEVY EQUITY MANAGEMENT, INC holds 2.9M shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), worth $98.2M as of 2026-Q2. The position was increased (+105.4% shares). RARE represents 0.4% of JACOBS LEVY EQUITY MANAGEMENT, INC's portfolio.
Current Value
$98.2M
Current Shares
2.9M
Total Value Change
+$92.7M
Total Shares Change
+2.8M
Quarter-by-Quarter History
Other major holders of RARE: Capital Research Global Investors, BNP PARIBAS FINANCIAL MARKETS, Capital International Investors